<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="14978">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02911883</url>
  </required_header>
  <id_info>
    <org_study_id>200-51133</org_study_id>
    <nct_id>NCT02911883</nct_id>
  </id_info>
  <brief_title>Evaluation of the Repeatability and Reproducibility of AngioVue</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Optovue</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Optovue</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the repeatability and reproducibility of measurements
      of the vascular structures and the anatomical structures of the posterior pole of the eye
      based on AngioVue volume scans in normal subjects, glaucoma patients, and retina patients.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retina vasculature</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">66</enrollment>
  <condition>Normal, Glaucoma &amp; Retinal Pathology</condition>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>Not having glaucoma or retinal pathology</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Glaucoma</arm_group_label>
    <description>Having glaucoma.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Retina</arm_group_label>
    <description>Having retinal pathology</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography Angiography</intervention_name>
    <arm_group_label>Normal</arm_group_label>
    <arm_group_label>Glaucoma</arm_group_label>
    <arm_group_label>Retina</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Seeing eye doctor for routine or follow-up care
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Normal

               -  Age &gt; 18.

               -  No retinal pathology or glaucoma.

          2. Glaucoma patient

               -  Age &gt; 18.

               -  Have glaucoma.

          3. Retina patient

               -  Age &gt; 18.

               -  Have retina pathology.

        Exclusion Criteria:

          1. Normal

               -  Unable to complete required exams.

               -  Poor quality image data.

          2. Glaucoma patient

               -  Unable to complete required exams.

               -  Poor quality image data.

               -  Retinal pathology.

          3. Retina patient

               -  Unable to complete required exams.

               -  Poor quality image data.

               -  Glaucoma.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 23, 2016</lastchanged_date>
  <firstreceived_date>September 20, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
